Other languages Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Real-time Estimate Cboe BZX Other stock markets 08:08:10 29/04/2024 pm IST			5-day change	1st Jan Change
1.58 ^USD	+7.48%		+0.61%	-84.00%

22/04	JPMorgan Downgrades Pacific Biosciences of California to Neutral From Overweight	MT
18/04	Scotiabank Adjusts Pacific Biosciences of California's Price Target to $8 From $15, Maintains Sector Outperform Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pacific Biosciences of California Q1 Revenue Expected to Be Flat Year Over Year; Guidance Lowered; Shares Sink	16/04
Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024	16/04
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes	27/03
PacBio Announces PureTarget Repeat Expansion Panel, Expanding Its Portfolio of End-To-End Clinical Research Solutions	12/03
Pacific Biosciences of California Q4 Non-GAAP Loss Narrows, Revenue Rises; Shares Drop After Hours	16/02
Pacific Biosciences of California, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02
Pacific Biosciences of California, Inc Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale	05/02
PacBio Announces New Nanobind Pandna Kit Enabling Hifi Optimized Dna Extraction Solutions	15/01
Pacific Biosciences Posts Higher Preliminary Q4, Full-Year 2023 Revenue	08/01
Pacific Biosciences of California, Inc. Announces Resignation of David Botstein from the Board	11/12
Pacific Biosciences of California Shares Rise After UBS Upgrade	18/11
PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders	02/11
Pacific Biosciences of California Teams Up With Geneyx, Golden Helix in Disease Research	01/11
PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible	01/11
Pacific Biosciences of California Q3 Loss Narrows, Revenue Gains	31/23/31
Pacific Biosciences of California, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	31/23/31
Pacific Biosciences of California, Inc. Appoints David Meline to Audit Committee	28/23/28
Pacific Biosciences of California, Inc. Appoints David Meline to its Board of Directors	16/23/16
Pacbio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis	11/23/11
Children's Mercy Kansas City First to Use 5-Base HiFi Sequencing from PacBio	06/23/06

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Other languages

Filters